Organisation: Teva Pharmaceutical Industries

Teva to be investigated by FTC, ramping up scrutiny of Orange Book listings

Antitrust challenges against pharma patent strategies continue to escalate

02 July 2024

Federal Circuit’s latest skinny label decision is another headache for generics

Appellate court hands down guidance on induced infringement cases

28 June 2024

Bristol-Myers wins one and loses one in Europe-wide Eliquis war

The wildly inconsistent decisions produced by the region’s national courts underscore the potential appeal of the Unified Patent Court

07 June 2024

Bayer handed lifeline by UK Court of Appeal in battle with Xarelto generics

European courts have been divided in a hard-fought struggle over the best-selling drug

30 April 2024

Unlock unlimited access to all IAM content